Clinical trial ML29741
A Single Arm, Open Label, Phase II, Multicenter Study To Assess The Detection Of The Braf V600 Mutation On cfDNA From Plasma In Patients With Advanced Melanoma
| Cancers | |
|---|---|
| Organ | Skin |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Roche |
| EudraCT Identifier | 2015-001731-20 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02768207 |
| Inclusion criteria | BRAF V600 mutation |
| Last update |